The Drugs Controller General of India (DCGI) recommended emergency use authorisation (EUA) for Bharat Biotech's Covaxin for children between 6 and 12 years. The DCGI has also recommended EUA for Biological E's Corbevax for children in the age group of 5 to 12 years and Zydus Cadila's ZyCoV-D for those above 12 years.
, one of the main vaccines administered to adults in India, is currently being administered to children in the age group of 15-18 years and all adults. The vaccine
is administered in two doses, with a gap of 28 days between the first and second doses.
is being used to inoculate children against COVID-19 in the age group of 12 to 14 years. Covaxin has been granted Emergency Use Listing (EUL) by the DCGI for the age group of 12 to 18 years on December 24, 2021.
India began inoculating children aged 12-14 on March 16. The countrywide vaccination drive was rolled out on January 16, 2021, with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started from February 2, 2021. The next phase of COVID-19 vaccination commenced on March 1, 2021, for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.
India launched vaccination for all people aged more than 45 years from April 1, 2021. The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1, 2021. The next phase of vaccination commenced on January 3 for adolescents in the age group of 15-18 years.
India began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from January 10. Precaution doses of COVID-19
vaccines to all aged above 18 years were allowed at private vaccination centres from April 10.
With inputs from PTI
First Published: Apr 26, 2022 1:02 PM IST